(NOVO-B) Novo Nordisk - Performance -52.9% in 12m
NOVO-B performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
39.76%
#10 in Peer-Group
Rel. Strength
8.76%
#7029 in Stock-Universe
Total Return 12m
-52.91%
#133 in Peer-Group
Total Return 5y
104.38%
#12 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 18.4 |
| P/E Forward | 16.6 |
| High / Low | DKK |
|---|---|
| 52 Week High | 950.39 DKK |
| 52 Week Low | 390.00 DKK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 20.49 |
| Buy/Sell Signal +-5 | -1.63 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NOVO-B (-52.9%) vs XBI (-11.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.74% | 53.2% | 70.2% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.64% | -10.3% | 158% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.83% | -8.28% | 33.6% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
7.39% | -7.29% | 0.13% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-1% | 26.9% | -7.57% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
4.06% | 31.3% | -17.2% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.56% | 41.9% | -8.93% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
- | 27% | 13.6% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: NOVO-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NOVO-B
| Total Return (including Dividends) | NOVO-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -13.11% | 7.34% | 5.42% |
| 3 Months | 8.72% | 16.06% | 19.66% |
| 12 Months | -52.91% | -11.67% | 14.17% |
| 5 Years | 104.38% | -26.49% | 107.98% |
| Trend Stabilty (consistency of price movement) | NOVO-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -40.6% | 88.2% | 91.9% |
| 3 Months | 32.7% | 79.7% | 97.6% |
| 12 Months | -94.5% | -86.7% | 47.9% |
| 5 Years | 87.8% | -51.5% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th8.00 | -19.06% | -17.58% |
| 3 Month | %th39.50 | -4.22% | -9.00% |
| 12 Month | %th34.00 | -46.69% | -58.76% |
| 5 Years | %th95.00 | 178.05% | -1.73% |
FAQs
Does Novo Nordisk (NOVO-B) outperform the market?
No,
over the last 12 months NOVO-B made -52.91%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.67%.
Over the last 3 months NOVO-B made 8.72%, while XBI made 16.06%.
Performance Comparison NOVO-B vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NOVO-B vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -7.3% | -18.5% | -30.8% | -67% |
| US NASDAQ 100 | QQQ | -8.1% | -19.4% | -33.1% | -70% |
| German DAX 40 | DAX | -6.6% | -17.1% | -41.2% | -84% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -7.8% | -19.2% | -34.6% | -72% |
| Hongkong Hang Seng | HSI | -8.5% | -17.6% | -51.3% | -88% |
| India NIFTY 50 | INDA | -6.5% | -15.3% | -32.6% | -50% |
| Brasil Bovespa | EWZ | -6.8% | -11.6% | -44.9% | -55% |
NOVO-B vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.9% | -16.5% | -35.2% | -79% |
| Consumer Discretionary | XLY | -6.4% | -18% | -21.7% | -69% |
| Consumer Staples | XLP | -6.9% | -14.5% | -31.4% | -59% |
| Energy | XLE | -4.6% | -11.7% | -18.8% | -49% |
| Financial | XLF | -6.6% | -18% | -30.4% | -75% |
| Health Care | XLV | -4.3% | -13% | -20.6% | -43% |
| Industrial | XLI | -7.6% | -19.9% | -36% | -75% |
| Materials | XLB | -4.5% | -16.8% | -28% | -53% |
| Real Estate | XLRE | -7.2% | -13.9% | -28.2% | -58% |
| Technology | XLK | -8.5% | -21.5% | -37% | -70% |
| Utilities | XLU | -6.7% | -16.3% | -31.1% | -74% |
| Aerospace & Defense | XAR | -13.2% | -26% | -54.5% | -105% |
| Biotech | XBI | -6.6% | -20.5% | -25.3% | -41% |
| Homebuilder | XHB | -3.5% | -23.2% | -18.1% | -45% |
| Retail | XRT | -5.1% | -17.6% | -27% | -56% |
NOVO-B vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -8% | -5.65% | -17.4% | -47% |
| Natural Gas | UNG | -13.4% | -2.4% | -10.7% | -67% |
| Gold | GLD | -7.4% | -11.7% | -48.5% | -88% |
| Silver | SLV | -9.6% | -15.8% | -50.6% | -78% |
| Copper | CPER | -5.1% | -27.1% | -50.4% | -77% |
NOVO-B vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -4.8% | -11.9% | -24.8% | -47% |
| iShares High Yield Corp. Bond | HYG | -6.9% | -14.5% | -28.9% | -62% |